Effective treatment of chemotherapy induced atypical Haemolytic Uraemic Syndrome: a case series of 7 treated patients

Br J Haematol. 2018 Oct;183(1):136-139. doi: 10.1111/bjh.14910. Epub 2017 Aug 31.

Authors

Ilene C Weitz¹, Thomas Deloughery²

Affiliations

¹ Jane Anne Nohl Division of Hematology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
² Knight Cancer Center, Oregon Health & Science Center, Portland, OR, USA.

PMID: 28857126
DOI: 10.1111/bjh.14910

No abstract available

Keywords: atypical haemolytic uraemic syndrome; chemotherapy; eculizumab.

Publication types

Letter

MeSH terms

Adult
Aged
Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / therapeutic use*
Antineoplastic Agents / adverse effects
Atypical Hemolytic Uremic Syndrome / chemically induced
Atypical Hemolytic Uremic Syndrome / drug therapy*
Atypical Hemolytic Uremic Syndrome / etiology
Atypical Hemolytic Uremic Syndrome / pathology
Complement C5 / antagonists & inhibitors
Endothelium / injuries
Endothelium / pathology
Female
Humans
Male
Middle Aged
Treatment Outcome
Young Adult

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Complement C5
eculizumab